Eli Lilly and Company develops and markets pharmaceuticals worldwide for various conditions, including diabetes, type 2 diabetes, obesity, oncology products, rheumatoid arthritis, psoriasis, ulcerative colitis, depression, anxiety disorders, fibromyalgia, osteoporosis, and more. Its products include Basaglar, Humalog, Jardiance, Mounjaro, Trulicity, Zepbound, and others. The company also collaborates with other organizations. Founded in 1876, Lilly is headquartered in Indiana.
| Indicator | Value |
|---|---|
| PER | 78.6 |
| EV/EBITDA | 44.5 |
| Price/Free Cash Flow | 2010.2 |
| ROIC | 18.4% |
| Net Debt/EBITDA | 1.6 |